275 related articles for article (PubMed ID: 24694992)
1. Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension.
Ohsawa M; Tamura K; Wakui H; Maeda A; Dejima T; Kanaoka T; Azushima K; Uneda K; Tsurumi-Ikeya Y; Kobayashi R; Matsuda M; Uchida S; Toya Y; Kobori H; Nishiyama A; Yamashita A; Ishikawa Y; Umemura S
Kidney Int; 2014 Sep; 86(3):570-81. PubMed ID: 24694992
[TBL] [Abstract][Full Text] [Related]
2. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
[TBL] [Abstract][Full Text] [Related]
3. Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
Kinguchi S; Wakui H; Azushima K; Haruhara K; Koguchi T; Ohki K; Uneda K; Matsuda M; Haku S; Yamaji T; Yamada T; Kobayashi R; Minegishi S; Ishigami T; Yamashita A; Fujikawa T; Tamura K
J Am Heart Assoc; 2019 Apr; 8(8):e012395. PubMed ID: 30977419
[TBL] [Abstract][Full Text] [Related]
4. Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.
Wakui H; Tamura K; Masuda S; Tsurumi-Ikeya Y; Fujita M; Maeda A; Ohsawa M; Azushima K; Uneda K; Matsuda M; Kitamura K; Uchida S; Toya Y; Kobori H; Nagahama K; Yamashita A; Umemura S
Hypertension; 2013 Jun; 61(6):1203-10. PubMed ID: 23529167
[TBL] [Abstract][Full Text] [Related]
5. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.
Tamura K; Azushima K; Kinguchi S; Wakui H; Yamaji T
Hypertens Res; 2022 Jan; 45(1):32-39. PubMed ID: 34642449
[TBL] [Abstract][Full Text] [Related]
6. An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
Kobayashi R; Wakui H; Azushima K; Uneda K; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Toya Y; Nishiyama A; Yamashita A; Tanabe K; Maeshima Y; Umemura S; Tamura K
Kidney Int; 2017 May; 91(5):1115-1125. PubMed ID: 28081856
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology.
Tamura K; Wakui H; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Yamashita A; Umemura S
Curr Med Chem; 2015; 22(28):3210-6. PubMed ID: 26295465
[TBL] [Abstract][Full Text] [Related]
8. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.
Wakui H; Tamura K; Matsuda M; Bai Y; Dejima T; Shigenaga A; Masuda S; Azuma K; Maeda A; Hirose T; Ishigami T; Toya Y; Yabana M; Minamisawa S; Umemura S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F991-F1003. PubMed ID: 20739392
[TBL] [Abstract][Full Text] [Related]
9. miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap.
Hirota K; Yamashita A; Abe E; Yamaji T; Azushima K; Tanaka S; Taguchi S; Tsukamoto S; Wakui H; Tamura K
J Biol Chem; 2023 Dec; 299(12):105478. PubMed ID: 37981211
[TBL] [Abstract][Full Text] [Related]
10. Renal nerve stimulation leads to the activation of the Na+/H+ exchanger isoform 3 via angiotensin II type I receptor.
Pontes RB; Crajoinas RO; Nishi EE; Oliveira-Sales EB; Girardi AC; Campos RR; Bergamaschi CT
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F848-56. PubMed ID: 25656367
[TBL] [Abstract][Full Text] [Related]
11. Atrap deficiency increases arterial blood pressure and plasma volume.
Oppermann M; Gess B; Schweda F; Castrop H
J Am Soc Nephrol; 2010 Mar; 21(3):468-77. PubMed ID: 20093357
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.
Uneda K; Wakui H; Maeda A; Azushima K; Kobayashi R; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Minegishi S; Ishigami T; Toya Y; Atobe Y; Yamashita A; Umemura S; Tamura K
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751545
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line.
Yamaji T; Yamashita A; Wakui H; Azushima K; Uneda K; Fujikawa Y; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Ishii T; Yamada T; Urate S; Suzuki T; Abe E; Tanaka S; Kamimura D; Ishigami T; Toya Y; Takahashi H; Tamura K
Sci Rep; 2019 Nov; 9(1):16550. PubMed ID: 31719572
[TBL] [Abstract][Full Text] [Related]
14. Proximal tubule-dominant transfer of AT(1a) receptors induces blood pressure responses to intracellular angiotensin II in AT(1a) receptor-deficient mice.
Li XC; Zhuo JL
Am J Physiol Regul Integr Comp Physiol; 2013 Apr; 304(8):R588-98. PubMed ID: 23427083
[TBL] [Abstract][Full Text] [Related]
15. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice.
Kamat NV; Thabet SR; Xiao L; Saleh MA; Kirabo A; Madhur MS; Delpire E; Harrison DG; McDonough AA
Hypertension; 2015 Mar; 65(3):569-76. PubMed ID: 25601932
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
Taguchi S; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Hirota K; Tsukamoto S; Morita R; Kobayashi R; Kinguchi S; Yamashita A; Wakui H; Tamura K
Hypertens Res; 2024 Jan; 47(1):55-66. PubMed ID: 37957242
[TBL] [Abstract][Full Text] [Related]
18. Renal NOXA1/NOX1 Signaling Regulates Epithelial Sodium Channel and Sodium Retention in Angiotensin II-induced Hypertension.
Vendrov AE; Stevenson MD; Lozhkin A; Hayami T; Holland NA; Yang X; Moss N; Pan H; Wickline SA; Stockand JD; Runge MS; Madamanchi NR; Arendshorst WJ
Antioxid Redox Signal; 2022 Mar; 36(7-9):550-566. PubMed ID: 34714114
[No Abstract] [Full Text] [Related]
19. Effect of Angiotensin II on ENaC in the Distal Convoluted Tubule and in the Cortical Collecting Duct of Mineralocorticoid Receptor Deficient Mice.
Wu P; Gao ZX; Zhang DD; Duan XP; Terker AS; Lin DH; Ellison DH; Wang WH
J Am Heart Assoc; 2020 Apr; 9(7):e014996. PubMed ID: 32208832
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019.
Wakui H
Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
